We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc. (AMGN)’s share was trading at $272.11 as of Jan 17th. AMGN’s trailing and forward P/E were 34.75 and 13.07 respectively according to Yahoo Finance.
A scientist holding a vial of the cancer-fighting drug developed by the biotechnology company.
Pharma stocks faced significant challenges in 2024, largely due to...
